These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12534605)

  • 41. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
    Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
    Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
    Wiegell SR; Petersen B; Wulf HC
    Br J Dermatol; 2014 Dec; 171(6):1487-92. PubMed ID: 25060803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
    Babilas P; Travnik R; Werner A; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Jan; 6(1):25-32. PubMed ID: 17995967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis.
    Song HS; Jung SE; Jang YH; Kang HY; Lee ES; Kim YC
    Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):296-301. PubMed ID: 26012779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
    Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
    Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.
    Szeimies RM; Karrer S; Radakovic-Fijan S; Tanew A; Calzavara-Pinton PG; Zane C; Sidoroff A; Hempel M; Ulrich J; Proebstle T; Meffert H; Mulder M; Salomon D; Dittmar HC; Bauer JW; Kernland K; Braathen L
    J Am Acad Dermatol; 2002 Aug; 47(2):258-62. PubMed ID: 12140473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.
    Hasson A; Navarrete-Dechent C; Nicklas C; de la Cruz C
    Indian J Dermatol Venereol Leprol; 2012; 78(4):448-53. PubMed ID: 22772615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
    Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
    Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
    Kaneko T; Chiba H; Yasuda T; Kusama K
    Oral Oncol; 2004 Sep; 40(8):787-92. PubMed ID: 15288832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current treatments of actinic keratosis.
    Gold MH; Nestor MS
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy.
    Fransson J; Ros AM
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):326-32. PubMed ID: 16313245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses.
    Hadley J; Tristani-Firouzi P; Hull C; Florell S; Cotter M; Hadley M
    Dermatol Surg; 2012 May; 38(5):722-7. PubMed ID: 22340282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
    Bissonnette R; Sharfaei S; Viau G; Liu Y
    Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
    Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
    Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
    Fai D; Romano I; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin.
    Torezan L; Chaves Y; Niwa A; Sanches JA; Festa-Neto C; Szeimies RM
    Dermatol Surg; 2013 Aug; 39(8):1197-201. PubMed ID: 23638986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.